Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema - Wikidata - wikimedia - TriplyDB

Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema

Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema

http://www.wikidata.org/entity/Q33559959

about

The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion Consensus Conference on Clinical Management of pediatric Atopic Dermatitis Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.Eczema.Atopic and non-atopic eczema.Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study A proposal: Atopic Dermatitis Organizer (ADO) guideline for children Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.A systematic review of the safety of topical therapies for atopic dermatitis.Pathways to managing atopic dermatitis: consensus from the experts Relationship between the usability and physicochemical properties of triamcinolone acetonide ointments.Update on the management of chronic eczema: new approaches and emerging treatment options The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application.How are eczema 'flares' defined? A systematic review and recommendation for future studies.Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate.Topical corticosteroids and hospital length of stay in children with eczema herpeticum.Topical corticosteroid prescribing patterns following changes in drug benefit status.Topical corticosteroids in atopic dermatitis.Are accelerometers a useful tool for measuring disease activity in children with eczema? Validity, responsiveness to change, and acceptability of use in a clinical trial setting.Acute and maintenance treatment of atopic dermatitis in children - two comparative studies with fluticasone propionate (0.05%) cream.Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis.'When it goes back to my normal I suppose': a qualitative study using online focus groups to explore perceptions of 'control' among people with eczema and parents of children with eczema in the UK.Eczema (atopic).Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis.A safety review of the medications used to treat atopic dermatitis.Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema.Steroid fears in children with eczema.

P2860

Q24799973-A5593171-038B-49AB-A41F-294E42A099B1 Q24806074-6BDCC63C-CAC6-4689-A64C-2B4530F50AFB Q28071974-EBAC47FB-A5C5-4E06-9220-0A8C8D0257E4 Q33684930-F04E4781-2518-46BE-8E52-53094215DF3B Q33910639-7FDA35ED-BA42-4205-94AE-929BB9933283 Q34441292-88CBB49E-58DC-45F1-B0A3-0D0744540E68 Q35077866-ED7878A8-2E92-482B-BA71-7C1A8853734E Q35107655-7B6DCB93-0EF2-4DC2-B743-C3ACA5D692E9 Q35502659-F1DAEC60-8607-4772-AF6C-13AE81A116CF Q35573947-74E3C532-3C7A-45FF-A67D-13F697D893DA Q36042131-A4444AE5-8D45-4602-BEA6-7D439EA11050 Q36708358-B8CB81A2-C9A6-47A7-A866-10680DFE10C0 Q37258723-D1D1E554-A7F9-435C-9281-D2E6E8E6E950 Q37614032-24229361-E77D-447B-BDB7-A6DE07660124 Q37857682-3DA6FC13-1020-489C-9F86-8E6DA54F1E85 Q38119984-F4D35063-8677-42FE-9846-B96629F7CAA7 Q38165233-5FB16C3E-0D59-44C0-81A0-95D163C734A9 Q39210471-C32EA11A-C70C-471A-BB1A-91FDE58BD157 Q39541512-6654583C-A0BB-41CC-AFF9-36862232E417 Q40585630-644E236C-4E06-4AE8-A080-059C1692DD4F Q43056856-D3E436E2-2777-444D-BC68-565949D53082 Q44314816-3EA6DE2E-CE65-4830-8D9C-467EB11E45CA Q44604970-B22F6E1E-17D7-4ED6-A92D-2BF31F1A6F8B Q45113271-9EA8D3C0-15E3-4A94-A119-04FDEE304B1B Q45927259-776CA9F4-AA51-4BAE-8E59-3DD7BEB61F82 Q46721613-13E90DFD-8C00-41C7-AD08-47BDD5304EE7 Q46745741-BF555898-3E2D-4121-8651-02417B1EF8B0 Q46868092-24EB8C4A-CC62-4FA8-88CD-BC1E01373AA5 Q47383323-5CB10BBA-E3FD-4324-B3A9-95FA26678C09 Q47712592-32211880-1F9C-4323-8D55-9007FC7AA5EA Q50920910-2378BBFE-564A-4A8D-BD14-D5486D6B62F6

P2860

Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema

http://www.wikidata.org/entity/Q33559959

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Randomised controlled trial of ...... mild or moderate atopic eczema

@ast

Randomised controlled trial of ...... mild or moderate atopic eczema

@en

Randomised controlled trial of ...... ild or moderate atopic eczema.

@nl

type

label

Randomised controlled trial of ...... mild or moderate atopic eczema

@ast

Randomised controlled trial of ...... mild or moderate atopic eczema

@en

Randomised controlled trial of ...... ild or moderate atopic eczema.

@nl

prefLabel

Randomised controlled trial of ...... mild or moderate atopic eczema

@ast

Randomised controlled trial of ...... mild or moderate atopic eczema

@en

Randomised controlled trial of ...... ild or moderate atopic eczema.

@nl

P1433

Q33559959-D5C8A612-5701-4487-937B-049C375AE108

P1476

Q33559959-B3961B7D-A507-4BEB-A155-6C059AB6913B

P2093

Q33559959-02B96E54-069B-4E22-ACEC-F3D0D46B12ED

Q33559959-337A45BE-674F-4D96-8E80-EB576BFE7639

Q33559959-71F33F9A-3374-4251-BE88-8C31F6B534CF

Q33559959-D147EA5B-AD27-4085-8654-74787B0F9FB1

Q33559959-D704BC25-0541-4FDB-87E4-8E9CEF01B824

Q33559959-DE497A12-B4F2-4279-A111-892CFC72971B

P2860

Q33559959-190FBB62-0C09-49CE-85C7-27AA762E7B10

Q33559959-1E6C535B-9795-441D-8AE6-C3BE91BFBCD5

Q33559959-5D651CAB-3656-4A7C-BC08-8FB4EE2EC95C

Q33559959-84132C13-22E7-42F6-BACF-6902603C39CF

Q33559959-8D789E63-81AA-4FA6-B61E-68207C030A90

Q33559959-CBAF8211-1B87-443C-8EF0-D71ACBD7774A

Q33559959-D7EF982F-431A-4E7E-B7EC-0B0DC014D2C1

Q33559959-DDEA5DBA-20ED-4785-ADE7-A67813873614

P304

Q33559959-69540BAD-D7C0-41BC-ACB6-565436ABC69F

P31

Q33559959-04828CDA-C917-4131-B0EF-C0044C82815E

P356

Q33559959-7087252A-46BC-4090-8055-51E98B270E05

P407

Q33559959-91A81C8C-B133-446F-A98E-C0481A64711B

P433

Q33559959-36E17B09-23C2-4900-8F57-0180DF823800

P478

Q33559959-87CE2645-47E3-486A-962C-C23E45B70AAF

P50

Q33559959-96D51D7D-863E-4770-A9A4-93672D6199A0

P577

Q33559959-CA87D9BB-9B42-4C09-B78D-80511126DFB2

P698

Q33559959-E1D038DD-D994-4FAC-BFEE-9606829CA87B

P932

Q33559959-3B374E11-097E-4CD1-9AE5-9D9169FBA40C

P356

BMJ.324.7340.768

P1433

P1476

Randomised controlled trial of ...... mild or moderate atopic eczema

@en

P2093

A Li Wan Po

http://www.w3.org/2001/XMLSchema#string

C O'Neill

http://www.w3.org/2001/XMLSchema#string

H C Williams

http://www.w3.org/2001/XMLSchema#string

K S Thomas

http://www.w3.org/2001/XMLSchema#string

S Armstrong

http://www.w3.org/2001/XMLSchema#string

S Young

http://www.w3.org/2001/XMLSchema#string

P2860

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group.

Outcome measures of disease severity in atopic eczema.

Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London.

Severity distribution of atopic dermatitis in the community and its relationship to secondary referral.

A reappraisal of topical steroid potency.

Topical corticosteroid phobia in patients with atopic eczema.

The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading.

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

P304

768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.324.7340.768

http://www.w3.org/2001/XMLSchema#string

P407

P433

7340

http://www.w3.org/2001/XMLSchema#string

P478

324

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11923161

http://www.w3.org/2001/XMLSchema#string

P932

100318

http://www.w3.org/2001/XMLSchema#string